Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Nano-X Imaging Ltd. (NNOX : NSDQ)
 
 • Company Description   
NANO-X IMAGING LTD is a medical imaging technology company. NANO-X IMAGING LTD is based in Neve Ilan, Israel.

Number of Employees: 165

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.84 Daily Weekly Monthly
20 Day Moving Average: 1,507,918 shares
Shares Outstanding: 69.59 (millions)
Market Capitalization: $128.05 (millions)
Beta: 1.19
52 Week High: $5.72
52 Week Low: $1.59
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 7.29% 2.05%
12 Week -25.81% -31.41%
Year To Date -34.29% -37.28%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
OFER TECH PARK 94 SHLOMO SHMELTZER ROAD
-
PETACH TIKVA,L3 4970602
ISR
ph: 9720337359202
fax: 9720337359203
mike.cavanaugh@westwicke.com None
 
 • General Corporate Information   
Officers
Erez Meltzer - Chief Executive Officer and Acting Chairman
Ran Daniel - Chief Financial Officer
Tamar Aharon - Executive Vice President and Chief Marketing Offic
Noga Kainan - Director
Dan Suesskind - Director

Peer Information
Nano-X Imaging Ltd. (ABMD)
Nano-X Imaging Ltd. (DMDS)
Nano-X Imaging Ltd. (CPWY.)
Nano-X Imaging Ltd. (EQUR)
Nano-X Imaging Ltd. (ECIA)
Nano-X Imaging Ltd. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: M70700105
SIC: 3844
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/25
Next Expected EPS Date: 04/20/26
Share - Related Items
Shares Outstanding: 69.59
Most Recent Split Date: (:1)
Beta: 1.19
Market Capitalization: $128.05 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.65 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 04/20/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.92
Price/Cash Flow: -
Price / Sales: 9.83
EPS Growth
vs. Year Ago Period: -117.39%
vs. Previous Quarter: 23.08%
Sales Growth
vs. Year Ago Period: 23.97%
vs. Previous Quarter: 7.89%
ROE
03/31/26 - -
12/31/25 - -64.65
09/30/25 - -48.75
ROA
03/31/26 - -
12/31/25 - -57.27
09/30/25 - -43.63
Current Ratio
03/31/26 - -
12/31/25 - 3.96
09/30/25 - 4.14
Quick Ratio
03/31/26 - -
12/31/25 - 3.77
09/30/25 - 3.93
Operating Margin
03/31/26 - -
12/31/25 - -790.87
09/30/25 - -680.11
Net Margin
03/31/26 - -
12/31/25 - -790.87
09/30/25 - -680.11
Pre-Tax Margin
03/31/26 - -
12/31/25 - -589.89
09/30/25 - -454.38
Book Value
03/31/26 - -
12/31/25 - 2.01
09/30/25 - 2.40
Inventory Turnover
03/31/26 - -
12/31/25 - 10.60
09/30/25 - 11.94
Debt-to-Equity
03/31/26 - -
12/31/25 - 0.00
09/30/25 - 0.00
Debt-to-Capital
03/31/26 - -
12/31/25 - 0.00
09/30/25 - 0.00
 

Powered by Zacks Investment Research ©